Clinical Trials Directory

Trials / Completed

CompletedNCT06725771

A Non-randomized Controlled Trial Was Conducted to Observe the Improvement in the Level of HAMA in Patients With Generalized Anxiety Disorder During the 6-week Period of Oral Treatment With Chaihu Jia Longgu Muli Tang (Bupleurum Plus Dragon Bone and Oyster Shell Decoction) Combined With Sertraline.

Clinical Study on the Treatment of Generalized Anxiety Disorder With Chaihu Jia Longgu Muli Tang (Bupleurum Plus Dragon Bone and Oyster Shell Decoction)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
205 (actual)
Sponsor
Lin Xiaoqian · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to clinically observe the efficacy of Bupleurum Plus Dragon Bone and Oyster Shell Decoction in the treatment of Generalized Anxiety Disorder to improve the scores of HAMA

Detailed description

Generalized Anxiety Disorder, not only results in a disturbed psychological condition, but even daily life with coworkers and family will also be disrupted. Chaihu Jia Longgu Muli Tang (Bupleurum Plus Dragon Bone and Oyster Shell Decoction), a compound Chinese herbal medicine found in "Treatise on Cold Damage", has been used for treating mental disorders with symptoms such as chest distress, irritability, being frightened, etc since the China Han dynasty. In this study, we will observe the efficacy of this formula, in order to provide an evidence-based basis for clinical observation and evaluation of Generalized Anxiety Disorder.

Conditions

Interventions

TypeNameDescription
DRUGBupleurum Plus Dragon Bone and Oyster Shell Decoction Combined with SertralineBupleurum Plus Dragon Bone and Oyster Shell Decoction and Sertraline are given to patients simultaneously
DRUGSertraline Hydrochloride TabletsSertraline are given to patients simultaneously

Timeline

Start date
2022-09-01
Primary completion
2024-10-31
Completion
2024-10-31
First posted
2024-12-10
Last updated
2024-12-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06725771. Inclusion in this directory is not an endorsement.